Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responses.
暂无分享,去创建一个
Daniel K. Bonner | J. Hubbell | M. Swartz | E. A. Phelps | Marcela Rincon-Restrepo | Aaron Mayer | Sylvie Hauert | Daniel K. Bonner | Edward A. Phelps | Jeffrey A. Hubbell | Melody A. Swartz | Sachiko Hirosue | Aaron T. Mayer | S. Hauert | M. Rincon-Restrepo | Sachiko Hirosue
[1] Anthony E. Gregory,et al. Vaccine delivery using nanoparticles , 2013, Front. Cell. Infect. Microbiol..
[2] N. Glaichenhaus,et al. Lymph Node Resident Rather Than Skin-Derived Dendritic Cells Initiate Specific T Cell Responses after Leishmania major Infection , 2006, The Journal of Immunology.
[3] R. Ahmed,et al. Humoral immunity due to long-lived plasma cells. , 1998, Immunity.
[4] Martin F. Bachmann,et al. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.
[5] Kutlu G. Elpek,et al. The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs , 2010, Nature Reviews Immunology.
[6] J. Vollmer,et al. In vitro effects of adjuvants on B cells. , 2010, Methods in molecular biology.
[7] Mikaël M. Martino,et al. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. , 2011, Vaccine.
[8] D. Irvine,et al. Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination , 2013, Science Translational Medicine.
[9] Steffen Jung,et al. Development and function of dendritic cell subsets. , 2014, Immunity.
[10] W. Heath,et al. The CD8+ dendritic cell subset , 2010, Immunological reviews.
[11] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[12] Michael Y. Gerner,et al. Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes. , 2012, Immunity.
[13] G. Otten. Antigen processing and presentation. , 1989, Current opinion in immunology.
[14] S. Plotkin,et al. The development of vaccines: how the past led to the future , 2011, Nature Reviews Microbiology.
[15] C. Mandl,et al. Vaccines for the twenty-first century society , 2012, Nature Reviews Immunology.
[16] J. Hubbell,et al. Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice , 2013, PloS one.
[17] B. Hinz,et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells , 2007, Nature Immunology.
[18] Darrell J Irvine,et al. Engineering synthetic vaccines using cues from natural immunity. , 2013, Nature materials.
[19] E. Shin,et al. CD8α(-) Dendritic Cells Induce Antigen-Specific T Follicular Helper Cells Generating Efficient Humoral Immune Responses. , 2015, Cell reports.
[20] T. Randall,et al. Priming of T follicular helper cells by dendritic cells , 2014, Immunology and cell biology.
[21] A. Rudensky,et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. , 2003, Immunity.
[22] L. Turka,et al. Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells. , 2008, Immunity.
[23] J. Hubbell,et al. Synthesis of pyridyl disulfide-functionalized nanoparticles for conjugating thiol-containing small molecules, peptides, and proteins. , 2010, Bioconjugate chemistry.
[24] D. Irvine,et al. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[25] V. Lukacs-Kornek,et al. The Mannose Receptor Mediates Uptake of Soluble but Not of Cell-Associated Antigen for Cross-Presentation1 , 2006, The Journal of Immunology.
[26] O. Joffre,et al. Cross-presentation by dendritic cells , 2012, Nature Reviews Immunology.
[27] Zhonggui He,et al. The endocytosis and intracellular fate of nanomedicines: Implication for rational design , 2013 .
[28] T. Blankenstein,et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. , 2004, Immunity.
[29] M. Akashi,et al. Amphiphilic Poly(Amino Acid) Nanoparticles Induce Size‐Dependent Dendritic Cell Maturation , 2010 .
[30] D. Irvine,et al. Synthetic Nanoparticles for Vaccines and Immunotherapy. , 2015, Chemical reviews.
[31] J. Hubbell,et al. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. , 2011, Vaccine.
[32] I. Toth,et al. Modern Subunit Vaccines: Development, Components, and Research Opportunities , 2013, ChemMedChem.
[33] Sai T Reddy,et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.
[34] R. Scheller,et al. Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] A. Jones,et al. Nanoparticle geometry and surface orientation influence mode of cellular uptake. , 2013, ACS nano.
[36] J. Hubbell,et al. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation. , 2010, Vaccine.
[37] Sven Burgdorf,et al. Distinct Pathways of Antigen Uptake and Intracellular Routing in CD4 and CD8 T Cell Activation , 2007, Science.
[38] Michael Y. Gerner,et al. Strategically localized dendritic cells promote rapid T cell responses to lymph-borne particulate antigens. , 2015, Immunity.
[39] W. Heath,et al. Dendritic cell subsets in primary and secondary T cell responses at body surfaces , 2009, Nature Immunology.
[40] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[41] S. Crotty,et al. Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.
[42] Jeffrey A Hubbell,et al. Oxidation-sensitive polymeric nanoparticles. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[43] A. Hill,et al. Malaria vaccines: the stage we are at , 2007, Nature Reviews Microbiology.
[44] R. Kroczek,et al. Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells , 2014, Mucosal Immunology.
[45] M. Merad,et al. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes , 2008, The Journal of experimental medicine.
[46] Hidde L. Ploegh,et al. The known unknowns of antigen processing and presentation , 2008, Nature Reviews Immunology.
[47] G. Schuler,et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. , 1999, Journal of immunological methods.
[48] Katrin Schwarz,et al. Nanoparticles target distinct dendritic cell populations according to their size , 2008, European journal of immunology.
[49] P. Andersen,et al. Tuberculosis vaccines--rethinking the current paradigm. , 2014, Trends in immunology.
[50] Michael Sixt,et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. , 2005, Immunity.
[51] J. Hubbell,et al. Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. , 2012, Biomaterials.
[52] J. Hubbell,et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination , 2011, Proceedings of the National Academy of Sciences.
[53] J. Dubrot,et al. Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological Implications , 2015, Front. Immunol..
[54] W. Heath,et al. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells , 2013, Nature Immunology.
[55] F. Sallusto,et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. , 2013, Immunity.
[56] J. Hubbell,et al. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles. , 2013, Biomaterials.
[57] Sai T Reddy,et al. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[58] J. Villadangos,et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. , 2006, Immunity.
[59] D. Irvine,et al. Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction , 2012, Proceedings of the National Academy of Sciences.
[60] Nadège Lagarde,et al. Isolation of murine lymph node stromal cells. , 2014, Journal of visualized experiments : JoVE.